nordihydroguaiaretic acid (NDGA)
GPTKB entity
Statements (28)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:chemical_compound
lignan |
gptkbp:canBe |
cancer research
antiviral research antidiabetic research |
gptkbp:CASNumber |
500-38-9
|
gptkbp:chemicalFormula |
C18H22O4
|
gptkbp:derivedFrom |
plant source
|
gptkbp:foundIn |
creosote bush (Larrea tridentata)
|
gptkbp:hasBiologicalActivity |
antioxidant
antineoplastic agent lipoxygenase inhibitor |
gptkbp:hasInChIKey |
YQHNNFFDMHYSNH-UHFFFAOYSA-N
|
gptkbp:hasSMILES |
CC(C)CC(C(C)C)OC1=CC=C(C=C1O)O
|
gptkbp:historicalName |
gptkb:traditional_medicine
|
https://www.w3.org/2000/01/rdf-schema#label |
nordihydroguaiaretic acid (NDGA)
|
gptkbp:IUPACName |
4,4'-[(2,3-dimethyl-1,4-butanediyl)bis(oxy)]bis(1,2-benzenediol)
|
gptkbp:meltingPoint |
175–176 °C
|
gptkbp:metabolism |
liver
|
gptkbp:molecularWeight |
302.37 g/mol
|
gptkbp:PubChem_CID |
4535
CHEBI:7626 |
gptkbp:solubility |
slightly soluble in water
soluble in ethanol |
gptkbp:toxicity |
hepatotoxic
nephrotoxic |
gptkbp:bfsParent |
gptkb:15-lipoxygenase_protein
|
gptkbp:bfsLayer |
7
|